Cargando…

The brain compensatory mechanisms and Alzheimer's disease progression: a new protective strategy

Detalles Bibliográficos
Autores principales:	Bobkova, Natalia, Vorobyov, Vasily
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468752/ https://www.ncbi.nlm.nih.gov/pubmed/26109935 http://dx.doi.org/10.4103/1673-5374.156954

Ejemplares similares

Intracerebral interplay and neurotransmitter systems involvement in animal models of neurodegenerative disorders: EEG approach expectations
por: Vorobyov, Vasily, et al.
Publicado: (2017)

Detrimental and synergistic role of epilepsy – Alzheimer’s disease risk factors
por: Filippov, Mikhail A., et al.
Publicado: (2019)

Dopaminergic mediation in the brain aging and neurodegenerative diseases: a role of senescent cells
por: Nekrasov, Pavel V., et al.
Publicado: (2018)

Acetylcholinesterase inhibitor modifications: a promising strategy to delay the progression of Alzheimer's disease
por: Bhattacharya, Soumee, et al.
Publicado: (2015)

APOE targeting strategy in Alzheimer’s disease: lessons learned from protective variants
por: Bu, Guojun
Publicado: (2022)

Microglial metabolic reconfiguration provides a new strategy for the treatment of Alzheimer’s disease
por: Leng, Lige, et al.
Publicado: (2023)

Compensatory Mechanisms in Early Alzheimer’s Disease and Clinical Setting: The Need for Novel Neuropsychological Strategies
por: Torrealba, Eduardo, et al.
Publicado: (2023)

Activation of tyrosine phosphatases in the progression of Alzheimer's disease
por: Stewart, Alexandre F. R., et al.
Publicado: (2020)

Brain ischemia as a bridge to Alzheimer’s disease
por: Pluta, Ryszard
Publicado: (2021)

Intrathecal corticosteroids might slow Alzheimer’s disease progression
por: Alisky, Joseph Martin
Publicado: (2008)

Calcium handling: a strategy to fight neurodegeneration in Alzheimer’s disease
por: La Barbera, Livia, et al.
Publicado: (2023)

New Approaches to Treating Alzheimer’s Disease
por: Zheng, Hailin, et al.
Publicado: (2015)

Electromagnetic protection strategy using adaptive energy selective mechanism
por: Liu, Peiguo, et al.
Publicado: (2023)

Neuropathological Mechanisms Associated with Pesticides in Alzheimer’s Disease
por: Tang, Bor Luen
Publicado: (2020)

Immunization Against Specific Fragments of Neurotrophin p75 Receptor Protects Forebrain Cholinergic Neurons in the Olfactory Bulbectomized Mice
por: Bobkova, Natalia, et al.
Publicado: (2016)

Discerning the Role of Blood Brain Barrier Dysfunction in Alzheimer’s Disease
por: Tao, Qing-Qing, et al.
Publicado: (2022)

Vascular dysfunction in Alzheimer’s disease: a biomarker of disease progression and a potential therapeutic target
por: Govindpani, Karan, et al.
Publicado: (2019)

A new mechanism for protection of dopaminergic neurons mediated by astrocytes
por: Segura-Aguilar, Juan
Publicado: (2015)

Brain network modulation in Alzheimer’s disease: clinical phenotypes and windows of opportunity
por: Pini, Lorenzo
Publicado: (2022)

Degenerative and regenerative processes in amyotrophic lateral sclerosis: motor reserve, adaptation and putative compensatory changes
por: Bede, Peter, et al.
Publicado: (2020)

Drug resistance in cancer: molecular evolution and compensatory proliferation
por: Friedman, Ran
Publicado: (2016)

Nose-to-brain drug delivery approach: a key to easily accessing the brain for the treatment of Alzheimer's disease
por: Alexander, Amit, et al.
Publicado: (2018)

Is blood-brain barrier a probable mediator of non-invasive brain stimulation effects on Alzheimer’s disease?
por: Petrovskaya, Aleksandra, et al.
Publicado: (2023)

Neuroprotection induced by NMDA preconditioning as a strategy to understand brain tolerance mechanism
por: Constantino, Leandra C., et al.
Publicado: (2015)

Aquaporin 5 in Alzheimer’s disease: a link between oral and brain pathology?
por: Municio, Cristina, et al.
Publicado: (2022)

Resistant and Resilient mutations in protection against familial Alzheimer’s disease: learning from nature
por: Sepulveda-Falla, Diego
Publicado: (2023)

Is it time to rethink the Alzheimer's disease drug development strategy by targeting its silent phase?
por: Souchet, Benoit, et al.
Publicado: (2018)

Leukocyte telomere length and plasma interleukin-1β and interleukin-18 levels in mild cognitive impairment and Alzheimer’s disease: new biomarkers for diagnosis and disease progression?
por: Corbo, Rosa Maria, et al.
Publicado: (2020)

Plasma amyloid-beta oligomer and phosphorylated tau: diagnostic tools for progressive Alzheimer’s disease
por: An, Seong Soo A., et al.
Publicado: (2023)

The therapeutic potential of mesenchymal stem cells in Alzheimer's disease: converging mechanisms
por: Turgeman, Gadi
Publicado: (2015)

Determining the mechanism behind yoga’s effects on preventing the symptoms of Alzheimer’s disease
por: Hassan, Adithy, et al.
Publicado: (2019)

Insights from human sleep research on neural mechanisms of Alzheimer’s disease
por: Cordone, Susanna, et al.
Publicado: (2020)

The blood-brain barrier models to study apolipoprotein E genotypes in Alzheimer's disease
por: Dias, Irundika HK, et al.
Publicado: (2022)

The Golgi apparatus: Site for convergence of COVID-19 brain fog and Alzheimer’s disease?
por: Wang, Yanzhuang, et al.
Publicado: (2022)

Hyperbaric oxygen therapy as a new treatment approach for Alzheimer’s disease
por: Shapira, Ronit, et al.
Publicado: (2018)

New approaches for prevention and treatment of Alzheimer's disease: a fascinating challenge
por: Piemontese, Luca
Publicado: (2017)

Direct oral anticoagulants: a new therapy against Alzheimer’s disease?
por: Grossmann, Klaus
Publicado: (2021)

Myelin lipid deficiency: a new key driver of Alzheimer’s disease
por: Qiu, Shulan, et al.
Publicado: (2022)

Galantamine protects against beta amyloid peptide-induced DNA damage in a model for Alzheimer's disease
por: Castillo, Willian O., et al.
Publicado: (2017)

Radio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer disease
por: Mannu, Piero, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_80henirs971kpvqfnqiaco1tgk